Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
A recent Australian legal decision means that, unless faculty members are bound by an assignment or intellectual property policy, they may own inventions resulting from their research.
An empirical study of the impact of patenting and licensing on regional manufacturing of human papilloma virus vaccines to help improve vaccine affordability and access.
Open biotechnology may be the ideal solution to ensure scientific progress and the realization of the common good, but it has yet to deliver on its promises.
Biotech inventors and patent practitioners alike need to be aware of new interpretations of what is considered patentable, and draft claims that extend beyond biological principles.